Cart 0 $0.00
IRE favicon


Resource ID: #18090
Subject: Pharmaceuticals
Source: Wall Street Journal (New York)
Date: 2022-03-07



A Wall-Street Journal analysis looks at the AIDS-drug market, and finds that "pharmaceutical giants seek to blunt a growing threat from generic-drug companies and recoup some moral high ground amid the crippling epidemic." The story reports on the slashing of the prices by the biggest drug-makers. It also includes a table of prices for AIDS per patient per year in the U.S. and Africa offered by large drug makers and two Indian generic drug companies.

This file is not available for digital download. IRE members may place an order by emailing

109 Lee Hills Hall, Missouri School of Journalism   |   221 S. Eighth St., Columbia, MO 65201   |   573-882-2042   |   |   Privacy Policy
apartmentpenciluserscalendar-fullcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram
My cart
Your cart is empty.

Looks like you haven't made a choice yet.